{"id": "covid_fact-000001", "label": "SUPPORTED", "statement": "Measuring sars-cov-2 neutralizing antibody activity using pseudotyped and chimeric viruses", "evidences": ["While each surrogate virus exhibited subtle differences in the sensitivity with which neutralizing activity was detected, the neutralizing activity of both convalescent plasma and human monoclonal antibodies measured using each virus correlated quantitatively with neutralizing activity measured using an authentic SARS-CoV-2 neutralization assay.", "Here, we describe a collection of approaches based on SARS-CoV-2 spike-pseudotyped, single-cycle, replication-defective human immunodeficiency virus type-1 (HIV-1) and vesicular stomatitis virus (VSV), as well as a replication-competent VSV/SARS- CoV-2 chimeric virus."], "model_verdict": "SUPPORTED", "explanation": "The evidence explicitly states that pseudotyped viruses (HIV-1 and VSV) and a chimeric virus (VSV/SARS-CoV-2) were used to measure neutralizing antibody activity, aligning with the claim.", "faithfulness_score": 0.4}
{"id": "covid_fact-000002", "label": "NOT_SUPPORTED", "statement": "Measuring chs-cov-2 neutralizing antibody activity using pseudotyped and chimeric viruses", "evidences": ["While each surrogate virus exhibited subtle differences in the sensitivity with which neutralizing activity was detected, the neutralizing activity of both convalescent plasma and human monoclonal antibodies measured using each virus correlated quantitatively with neutralizing activity measured using an authentic SARS-CoV-2 neutralization assay.", "Here, we describe a collection of approaches based on SARS-CoV-2 spike-pseudotyped, single-cycle, replication-defective human immunodeficiency virus type-1 (HIV-1) and vesicular stomatitis virus (VSV), as well as a replication-competent VSV/SARS- CoV-2 chimeric virus."], "model_verdict": "SUPPORTED", "explanation": "The evidence clearly describes the use of pseudotyped and chimeric viruses to measure neutralizing antibody activity against SARS-CoV-2, confirming the claim.", "faithfulness_score": 1.0}
{"id": "covid_fact-000003", "label": "NOT_SUPPORTED", "statement": "Measuring aces-cov-2 neutralizing antibody activity using pseudotyped and chimeric viruses", "evidences": ["While each surrogate virus exhibited subtle differences in the sensitivity with which neutralizing activity was detected, the neutralizing activity of both convalescent plasma and human monoclonal antibodies measured using each virus correlated quantitatively with neutralizing activity measured using an authentic SARS-CoV-2 neutralization assay.", "Here, we describe a collection of approaches based on SARS-CoV-2 spike-pseudotyped, single-cycle, replication-defective human immunodeficiency virus type-1 (HIV-1) and vesicular stomatitis virus (VSV), as well as a replication-competent VSV/SARS- CoV-2 chimeric virus."], "model_verdict": "SUPPORTED", "explanation": "The evidence details the use of pseudotyped HIV-1 and VSV viruses as well as a chimeric VSV/SARS-CoV-2 virus to measure neutralizing antibody activity against SARS-CoV-2, confirming the claim.", "faithfulness_score": 1.0}
{"id": "covid_fact-000004", "label": "NOT_SUPPORTED", "statement": "Measuring gps-cov-2 neutralizing antibody activity using pseudotyped and chimeric viruses", "evidences": ["While each surrogate virus exhibited subtle differences in the sensitivity with which neutralizing activity was detected, the neutralizing activity of both convalescent plasma and human monoclonal antibodies measured using each virus correlated quantitatively with neutralizing activity measured using an authentic SARS-CoV-2 neutralization assay.", "Here, we describe a collection of approaches based on SARS-CoV-2 spike-pseudotyped, single-cycle, replication-defective human immunodeficiency virus type-1 (HIV-1) and vesicular stomatitis virus (VSV), as well as a replication-competent VSV/SARS- CoV-2 chimeric virus."], "model_verdict": "SUPPORTED", "explanation": "The evidence explicitly describes the use of pseudotyped (HIV-1 and VSV) and chimeric viruses to measure neutralizing antibody activity against SARS-CoV-2, which aligns with the claim.", "faithfulness_score": 0.3333333333333333}
{"id": "covid_fact-000005", "label": "SUPPORTED", "statement": "Long-term persistence of igg antibodies in sars-cov infected healthcare workers", "evidences": ["IgG titers in SARS-CoV-infected healthcare workers remained at a significantly high level until 2015.", "All sera were tested for IgG antibodies with ELISA using whole virus and a recombinant nucleocapsid protein of SARS- CoV, as a diagnostic antigen.", "CONCLUSIONS IgG antibodies against SARS-CoV can persist for at least 12 years."], "model_verdict": "SUPPORTED", "explanation": "The evidence clearly shows that IgG antibodies in healthcare workers infected with SARS-CoV persisted at high levels until 2015 and can last for at least 12 years, directly supporting the claim.", "faithfulness_score": 1.0}
{"id": "covid_fact-000006", "label": "NOT_SUPPORTED", "statement": "short-term persistence of igg antibodies in sars-cov infected healthcare workers", "evidences": ["IgG titers in SARS-CoV-infected healthcare workers remained at a significantly high level until 2015.", "All sera were tested for IgG antibodies with ELISA using whole virus and a recombinant nucleocapsid protein of SARS- CoV, as a diagnostic antigen.", "CONCLUSIONS IgG antibodies against SARS-CoV can persist for at least 12 years."], "model_verdict": "NOT_SUPPORTED", "explanation": "The evidence shows that IgG antibodies persisted for at least 12 years, which contradicts the claim of 'short-term persistence.'", "faithfulness_score": 0.5}
{"id": "covid_fact-000007", "label": "NOT_SUPPORTED", "statement": "Low-term persistence of igg antibodies in sars-cov infected healthcare workers", "evidences": ["IgG titers in SARS-CoV-infected healthcare workers remained at a significantly high level until 2015.", "All sera were tested for IgG antibodies with ELISA using whole virus and a recombinant nucleocapsid protein of SARS- CoV, as a diagnostic antigen.", "CONCLUSIONS IgG antibodies against SARS-CoV can persist for at least 12 years."], "model_verdict": "NOT_SUPPORTED", "explanation": "The evidence indicates that IgG antibodies persist for at least 12 years in SARS-CoV-infected healthcare workers, contradicting the claim of low-term persistence.", "faithfulness_score": 0.5}
{"id": "covid_fact-000008", "label": "NOT_SUPPORTED", "statement": "Pre-term persistence of igg antibodies in sars-cov infected healthcare workers", "evidences": ["IgG titers in SARS-CoV-infected healthcare workers remained at a significantly high level until 2015.", "All sera were tested for IgG antibodies with ELISA using whole virus and a recombinant nucleocapsid protein of SARS- CoV, as a diagnostic antigen.", "CONCLUSIONS IgG antibodies against SARS-CoV can persist for at least 12 years."], "model_verdict": "SUPPORTED", "explanation": "The evidence shows that IgG titers in SARS-CoV-infected healthcare workers remained high until 2015 and can persist for at least 12 years, which directly supports the claim about pre-term persistence.", "faithfulness_score": 0.6666666666666666}
